发明名称 NOVEL TRPM8 INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide a novel α-substituted glycine amide derivative, or a pharmaceutical composition containing pharmacologically acceptable salt thereof, and a medicinal use thereof.SOLUTION: The present invention provides a compound expressed by a general formula (I) having TRPM8 inhibitory action (in the formula, Adenotes Caryl or the like, Adenotes Caryl or the like, X denotes CH or the like, Y denotes -CRR- or the like, Rand Rdenote hydrogen atom or the like independently, Rand Rdenote halogen atom or the like independently, and n denotes 1 or 2), or a pharmaceutical composition containing pharmacologically acceptable salt thereof. Furthermore, a pharmaceutical composition of the present invention is usable as treatment or a prophylactic drug of disease or symptom caused by hyperexcitement or disorder of afferent nerves.SELECTED DRAWING: None
申请公布号 JP2016094407(A) 申请公布日期 2016.05.26
申请号 JP20150218309 申请日期 2015.11.06
申请人 KISSEI PHARMACEUTICAL CO LTD 发明人 HIRASAWA HIDEAKI;KAWAMURA NAOHIRO;KOBAYASHI JUNICHI
分类号 A61K31/166;A61K31/343;A61K31/36;A61K31/381;A61K31/415;A61K31/4164;A61K31/42;A61K31/421;A61K31/4245;A61K31/425;A61K31/426;A61K31/435;A61K31/437;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/443;A61K31/4436;A61K31/4439;A61K31/455;A61K31/47;A61K31/472;A61K31/4965;A61K31/4985;A61K31/50;A61K31/505;A61K31/5377;A61P13/02;A61P13/08;A61P13/10;A61P25/00;A61P25/04;A61P25/22;A61P25/24;C07D213/56;C07D213/81;C07D213/82;C07D213/84;C07D215/54;C07D217/26;C07D231/14;C07D233/90;C07D237/08;C07D237/24;C07D239/26;C07D239/28;C07D241/12;C07D241/24;C07D261/18;C07D263/34;C07D271/08;C07D275/02;C07D275/03;C07D277/30;C07D277/56;C07D307/78;C07D307/82;C07D317/62;C07D333/38;C07D333/70;C07D405/12;C07D409/12;C07D417/12;C07D471/04;C07D487/04 主分类号 A61K31/166
代理机构 代理人
主权项
地址